PATENT CLAIM ANALYSIS

Application Number: 15866043
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "279000"]

Abstract:
A depot precursor formulation comprising: a) a controlled-release matrix; b) at least oxygen containing organic solvent; c) at least 12% by weigh of at least one active agent selected from buprenorphine and salts thereof, calculated as buprenorphine free base.   Corresponding depot compositions and methods of treatment in pain management, by opioid maintenance and related methods are provided.

Claim (Index 53):
A method of  claim 52  for:\n (i) the treatment of pain or the treatment of opioid dependence by at least one of: detoxification and maintenance; \n (ii) opioid maintenance therapy by at least one of: detoxification and maintenance; or \n (iii) the treatment or prophylaxis of the symptoms of at least one of: opioid withdrawal and cocaine withdrawal.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14416421', '11798495', '14362517', '11628007', '11795249']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8007906555078111
- 35 USC 102 Novelty (BERT): 0.5941417608917394
- Combined Prediction Score: 0.780125766046204
- Mean Citation Score: 342.746164
- Max Citation Score: 518.8724
- Similarity Product: 448.14383038280016

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test